1. 2399 Impact of KRAS mutations on clinical outcomes in advanced refractory pancreatic cancer patients. (September 2015) Authors: Sauri, T.; Macarulla, T.; Sanz-Garcia, E.; Moreno, D.; Vilaro, M.; Vivancos, A.; Elez, E.; Argil és, G.; Grasselli, J.; Capdevila, J.; Alsina, M.; Hierro, C.; Matos, I.; Dientsmann, R.; Nuciforo, P.; Tabernero, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mutational profile applicability in the prognosis of resected colorectal liver metastases beyond the classical clinical risk score. (September 2018) Authors: Dopazo-Taboada, C.; Sauri, T.; Herrando, A.; Hernández, J.; Vivancos, A.; Nuciforo, P.; Charco, R.; Dientsmann, R.; Tabernero, J.; Elez, E. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗